| # | Drug | Count |
|---|---|---|
| 0 | LENALIDOMIDE | 26 |
| 1 | ASPIRIN 81 MG | 22 |
| 2 | ASPIRIN | 21 |
| 3 | ASPIRIN 325 MG | 21 |
| 4 | BISOPROLOL FUMARATE | 13 |
| 5 | CLOZAPINE | 13 |
| 6 | ACETAMINOPHEN | 12 |
| 7 | PEGINTERFERON ALFA-2A | 12 |
| 8 | LEVOTHYROXINE SODIUM | 11 |
| 9 | MELPHALAN | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OLUTASIDENIB | 2 | 0.0069 |
| 1 | FERROUS FUMARATE AND POLYSACCHRIDE IRON VITAMIN MINERAL COMPLEX SUPPLEMENT | 1 | 0.0051 |
| 2 | ACETAMINOPHEN, IBUPROFEN | 1 | 0.0027 |
| 3 | CEFPROZIL | 2 | 0.0026 |
| 4 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0016 |
| 5 | BUTALBITAL AND ACETAMINOPHEN | 1 | 0.0016 |
| 6 | TEDIZOLID PHOSPHATE | 1 | 0.0012 |
| 7 | CAMPHOR, MENTHOL | 1 | 0.0012 |
| 8 | OXAPROZIN | 1 | 0.0011 |
| 9 | CEFTOLOZANE AND TAZOBACTAM | 1 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 38 |
| 1 | Thalidomide Analog [EPC] | 35 |
| 2 | Corticosteroid [EPC] | 26 |
| 3 | Kinase Inhibitor [EPC] | 23 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 22 |
| 5 | Atypical Antipsychotic [EPC] | 21 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 16 |
| 7 | Benzodiazepine [EPC] | 15 |
| 8 | Interferon alpha [EPC] | 12 |
| 9 | Leukocyte Growth Factor [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 2 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 3 | Calcitonin [EPC] | 1 | 0.0003 |
| 4 | Cephalosporin Antibacterial [EPC] | 2 | 0.0002 |
| 5 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 6 | Thymic Stromal Lymphopoietin Blocker [EPC] | 1 | 0.0001 |
| 7 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Interleukin-17A Antagonist [EPC] | 4 | 0.0001 |
| 9 | Estrogen Receptor Antagonist [EPC] | 4 | 0.0001 |